BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28987314)

  • 1. Use of Prophylactic Ondansetron with Intravenous Opioids in Emergency Department Patients: A Prospective Observational Pilot Study.
    Culver MA; Richards EC; Jarrell DH; Edwards CJ
    J Emerg Med; 2017 Nov; 53(5):629-634. PubMed ID: 28987314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
    Hardy J; Daly S; McQuade B; Albertsson M; Chimontsi-Kypriou V; Stathopoulos P; Curtis P
    Support Care Cancer; 2002 Apr; 10(3):231-6. PubMed ID: 11904788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind pilot study examining the use of intravenous ondansetron in the prevention of postoperative nausea and vomiting in female inpatients.
    McKenzie R; Sharifi-Azad S; Dershwitz M; Miguel R; Joslyn AF; Tantisira B; Rosenblum F; Rosow CE; Downs JB; Bowie JR
    J Clin Anesth; 1993; 5(1):30-6. PubMed ID: 8442964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Ondansetron OIE Post-Surgical Study Group.
    Chung F; Lane R; Spraggs C; McQuade B; Jacka M; Luttropp HH; Alahuta S; Rocherieux S; Roy M; Duvaldestin P; Curtis P
    Eur J Anaesthesiol; 1999 Oct; 16(10):669-77. PubMed ID: 10583349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
    Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous ondansetron for postsurgical opioid-induced nausea and vomiting. S3A-255 Study Group.
    Rung GW; Claybon L; Hord A; Patel C; Kallgren M; Koppel J; Benedetti C; Creed M; Asgharian A; Bryson J
    Anesth Analg; 1997 Apr; 84(4):832-8. PubMed ID: 9085967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.
    Tsukuura H; Miyazaki M; Morita T; Sugishita M; Kato H; Murasaki Y; Gyawali B; Kubo Y; Ando M; Kondo M; Yamada K; Hasegawa Y; Ando Y
    Oncologist; 2018 Mar; 23(3):367-374. PubMed ID: 29038236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should Antiemetics be Given Prophylactically with Intravenous Opioids While Treating Acute Pain in the Emergency Department?: Clinical Practice Paper Approved by American Academy of Emergency Medicine Clinical Guidelines Committee.
    Rowland KD; Fuehrer J; Motov SM; Vilke G; Rosenbaum SB; Quenzer F
    J Emerg Med; 2020 Apr; 58(4):706-709. PubMed ID: 32216978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of timing of ondansetron administration in outpatients undergoing otolaryngologic surgery.
    Sun R; Klein KW; White PF
    Anesth Analg; 1997 Feb; 84(2):331-6. PubMed ID: 9024023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.
    Hesketh P; Navari R; Grote T; Gralla R; Hainsworth J; Kris M; Anthony L; Khojasteh A; Tapazoglou E; Benedict C; Hahne W
    J Clin Oncol; 1996 Aug; 14(8):2242-9. PubMed ID: 8708713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.
    Egerton-Warburton D; Meek R; Mee MJ; Braitberg G
    Ann Emerg Med; 2014 Nov; 64(5):526-532.e1. PubMed ID: 24818542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and Nursing Staff Education Reduces Use of Prophylactic Ondansetron With Opioids in the Emergency Department.
    Bakhsh HT; Perona SJ
    J Emerg Nurs; 2019 May; 45(3):273-277. PubMed ID: 30126617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevention of emesis in plastic surgery: a randomized, prospective study.
    Marcus JR; Few JW; Chao JD; Fine NA; Mustoe TA
    Plast Reconstr Surg; 2002 Jun; 109(7):2487-94. PubMed ID: 12045581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron is safe and effective for prehospital treatment of nausea and vomiting by paramedics.
    Salvucci AA; Squire B; Burdick M; Luoto M; Brazzel D; Vaezazizi R
    Prehosp Emerg Care; 2011; 15(1):34-8. PubMed ID: 21091329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic iv ondansetron reduces nausea, vomiting and pruritus following epidural morphine for postoperative pain control.
    Tzeng JI; Chu KS; Ho ST; Cheng KI; Liu KS; Wang JJ
    Can J Anaesth; 2003 Dec; 50(10):1023-6. PubMed ID: 14656780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprepitant for antiemesis after laparoscopic gynaecological surgery: A randomised controlled trial.
    Ham SY; Shim YH; Kim EH; Son MJ; Park WS; Lee JS
    Eur J Anaesthesiol; 2016 Feb; 33(2):90-5. PubMed ID: 26694939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section.
    Koju RB; Gurung BS; Dongol Y
    BMC Anesthesiol; 2015 Feb; 15():18. PubMed ID: 25971957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group.
    Sussman G; Shurman J; Creed MR; Larsen LS; Ferrer-Brechner T; Noll D; Allegra J; Montgomery R; Schreck D; Grafstein E; Ramalanjaona G; Patel V; Ducharme J; Ortenwall P; Foster E; Ames M
    Clin Ther; 1999 Jul; 21(7):1216-27. PubMed ID: 10463519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
    Jeremić B
    Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of metoclopramide and ondansetron for the prevention of nausea and vomiting after intrathecal morphine.
    Pitkänen MT; Numminen MK; Tuominen MK; Rosenberg PH
    Eur J Anaesthesiol; 1997 Mar; 14(2):172-7. PubMed ID: 9088816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.